Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics

Johannes A. Kroes, Kim de Jong, Simone Hashimoto, Sander W. Zielhuis, Eric N. van Roon, Jacob K. Sont, Anneke ten Brinke

Source: ERJ Open Res, 9 (2) 00559-2022; 10.1183/23120541.00559-2022
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Johannes A. Kroes, Kim de Jong, Simone Hashimoto, Sander W. Zielhuis, Eric N. van Roon, Jacob K. Sont, Anneke ten Brinke. Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics. ERJ Open Res, 9 (2) 00559-2022; 10.1183/23120541.00559-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.